Status:
RECRUITING
Metabolic Exercise Test Data Combined with Cardiac and Kidney Indexes (MECKI) Score Evolution: Identification of Cardiovascular Risk in Patients with Heart Failure
Lead Sponsor:
Centro Cardiologico Monzino
Collaborating Sponsors:
Santo Spirito Hospital, Italy
Fondazione Toscana Gabriele Monasterio
Conditions:
Heart Failure
Eligibility:
All Genders
18+ years
Brief Summary
Heart failure is a complex condition involving multiple organs beyond the cardiovascular system, all influencing disease progression and prognosis. Accurate risk assessment requires considering multip...
Detailed Description
Heart failure is a complex condition affecting multiple organs beyond the cardiovascular system, influencing disease progression and prognosis. It has become increasingly evident that accurate risk as...
Eligibility Criteria
Inclusion
- age \>18 past or present heart failure (NYHA functional class I-III, stage C of the ACC/AHA classification)
- documentation of left ventricular systolic dysfunction (LVEF \<40%)
- stable clinical conditions
- previous or concomitant cardiopulmonary exercise test
Exclusion
- scheduled cardiovascular treatment
- clinical unstable condition
- History of pulmonary embolism, significant valvular disease, pericardial disease, severe COPD, exercise-induced angina, exercise-induced ECG changes, severe brady- or tachyarrhythmias, or the presence of comorbidities that interfere with exercise performance.
Key Trial Info
Start Date :
February 10 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2028
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT06884631
Start Date
February 10 2021
End Date
December 31 2028
Last Update
March 19 2025
Active Locations (26)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro Cardiologico Monzino
Milan, Italy, Italy, 20138
2
Ospedali Riuniti di Ancona
Ancona, Italy
3
Istituti Clinici Scientifici Maugeri Bari
Bari, Italy
4
Ospedale papa Giovanni XXIII
Bergamo, Italy